Scholarlink

Background <p>Cervical cancer remains a major public health concern in Nigeria, particularly among women living with HIV (WLHIV). While treatable if detected early, many WLHIV do not access cervical cancer screening and treatment services. Accordingly, the Accelerating Cervical Cancer Elimination through the integration of Screen-and-treat Services (ACCESS) Study aims to test implementation strategies to enhance cervical cancer screening and treatment among WLHIV in 12 Nigeria Implementation Science Alliance Model Innovation and Research Centers (NISA-MIRCs) of the ICON-3 Practice Based Research Network.</p> Methods <p>Prior to the trial commencement, we conducted a baseline cross-sectional study to assess cervical cancer screening, pre-cancer treatment, and referral for suspected cancer treatment at the 12 NISA-MIRCs. Data were obtained from electronic medical records and analyzed with descriptive statistics.</p> Results <p>Out of 23,409 WLHIV who visited the sites during a six-month period (March to August 2023), 13,518 (57.7%) were eligible for screening, but only 4,499 (33.3%) were screened. The South West had the highest screening rate (65.5%), while the North West had the lowest (22.4%). Of the 112 WLHIV (2.7%) who screened positive with visual inspection with acetic acid (VIA), 73.2% were treated on-site. Twenty-three (0.5%) of those screened had suspected cancer, out of which 15 (65.2%) were referred to an oncology center.</p> Conclusions <p>The results show significant gaps in cervical cancer prevention services in Nigeria and considerable regional disparities. There is a need for implementation research studies, such as ACCESS, to identify effective strategies for improved cervical cancer screening and treatment among WLHIV in Nigeria.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Cervical cancer screen-and-treat services at HIV treatment sites in Nigeria: findings from the ICON-3 Practice Based Research Network

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年2月20日

查看全文
  • Chibuike O. Chigbu,
  • Cyril C. Dim,
  • Stanley C. Eneh,
  • Babayemi O. Olakunde,
  • John O. Olawepo,
  • Tonia C. Onyeka,
  • Ijeoma U. Itanyi,
  • Ngozi Idemili-Aronu,
  • Nwamaka N. Lasebikan,
  • Chinenye Bembir,
  • Esther Audu,
  • Omeje Ejiofor,
  • Nicholas Hamman,
  • Sagir Muhammad,
  • Atakulu Lawrence,
  • Odufunke Maijeh,
  • Onyeji John,
  • Idayat Yinusa,
  • Bala Barka,
  • Aisha Abdulrahmeen,
  • Ezechukwu Paschalina,
  • Obuchuku Nwafor,
  • Gregory A. Aarons,
  • Echezona E. Ezeanolue

摘要

Background

Cervical cancer remains a major public health concern in Nigeria, particularly among women living with HIV (WLHIV). While treatable if detected early, many WLHIV do not access cervical cancer screening and treatment services. Accordingly, the Accelerating Cervical Cancer Elimination through the integration of Screen-and-treat Services (ACCESS) Study aims to test implementation strategies to enhance cervical cancer screening and treatment among WLHIV in 12 Nigeria Implementation Science Alliance Model Innovation and Research Centers (NISA-MIRCs) of the ICON-3 Practice Based Research Network.

Methods

Prior to the trial commencement, we conducted a baseline cross-sectional study to assess cervical cancer screening, pre-cancer treatment, and referral for suspected cancer treatment at the 12 NISA-MIRCs. Data were obtained from electronic medical records and analyzed with descriptive statistics.

Results

Out of 23,409 WLHIV who visited the sites during a six-month period (March to August 2023), 13,518 (57.7%) were eligible for screening, but only 4,499 (33.3%) were screened. The South West had the highest screening rate (65.5%), while the North West had the lowest (22.4%). Of the 112 WLHIV (2.7%) who screened positive with visual inspection with acetic acid (VIA), 73.2% were treated on-site. Twenty-three (0.5%) of those screened had suspected cancer, out of which 15 (65.2%) were referred to an oncology center.

Conclusions

The results show significant gaps in cervical cancer prevention services in Nigeria and considerable regional disparities. There is a need for implementation research studies, such as ACCESS, to identify effective strategies for improved cervical cancer screening and treatment among WLHIV in Nigeria.